Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dexmedetomidine Versus Chloral Hydrate for Pediatric Sedation During EEG

This study has been withdrawn prior to enrollment.
(Unable to obtain approval from FDA for use of chloral hydrate)
Sponsor:
Collaborator:
Hospira, Inc.
Information provided by (Responsible Party):
Lindall E.Smith, Wesley Medical Center
ClinicalTrials.gov Identifier:
NCT00464451
First received: April 19, 2007
Last updated: November 1, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: May 2011
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)